Celgene plunges to new 52-week low despite beating Q3 estimates

Celgene Corp. (CELG) reported better-than-expected profit and revenue numbers for the third quarter of 2018 on strong product sales. Revenue climbed 18% to $3.89 billion and EPS jumped 20% to … Continue reading Celgene plunges to new 52-week low despite beating Q3 estimates